InvestorsHub Logo

orangecat

10/13/18 12:58 AM

#13565 RE: B52T38 #13564

Adcomm vote 10 to 3 to approve for ARCX this afternoon. PDUFA date Nov. 2 for them I think. If you can get in early Monday it could be a good score. Long term, a great score. IV morphine alternative for ER and post surgery situations. Opioid, so it needs to be tightly controlled in the current US situation. There is a morphine shortage right now, plus it does not have the overhead cost of an IV. Also already EU approved, like Cytosorb, so FDA approval could instantly boost sales overseas.

mikesmith999945

10/13/18 9:28 PM

#13569 RE: B52T38 #13564

Make that two beers to OC and a nice dinner......I bought stock and options from that stock as well......